683 related articles for article (PubMed ID: 10047618)
1. Sotalol: An important new antiarrhythmic.
Anderson JL; Prystowsky EN
Am Heart J; 1999 Mar; 137(3):388-409. PubMed ID: 10047618
[TBL] [Abstract][Full Text] [Related]
2. From first class to third class: recent upheaval in antiarrhythmic therapy--lessons from clinical trials.
Lazzara R
Am J Cardiol; 1996 Aug; 78(4A):28-33. PubMed ID: 8780326
[TBL] [Abstract][Full Text] [Related]
3. Old and new antiarrhythmic drugs for converting and maintaining sinus rhythm in atrial fibrillation: comparative efficacy and results of trials.
Naccarelli GV; Wolbrette DL; Khan M; Bhatta L; Hynes J; Samii S; Luck J
Am J Cardiol; 2003 Mar; 91(6A):15D-26D. PubMed ID: 12670638
[TBL] [Abstract][Full Text] [Related]
4. Evolving role of sotalol in the management of ventricular tachyarrhythmias.
O'Callaghan PA; McGovern BA
Am J Cardiol; 1996 Aug; 78(4A):54-60. PubMed ID: 8780329
[TBL] [Abstract][Full Text] [Related]
5. Antiarrhythmic drugs in patients with implantable cardioverter-defibrillators.
Bollmann A; Husser D; Cannom DS
Am J Cardiovasc Drugs; 2005; 5(6):371-8. PubMed ID: 16259525
[TBL] [Abstract][Full Text] [Related]
6. Efficacy and proarrhythmia with the use of d,l-sotalol for sustained ventricular tachyarrhythmias.
Kühlkamp V; Mermi J; Mewis C; Seipel L
J Cardiovasc Pharmacol; 1997 Mar; 29(3):373-81. PubMed ID: 9125676
[TBL] [Abstract][Full Text] [Related]
7. A comparison of seven antiarrhythmic drugs in patients with ventricular tachyarrhythmias. Electrophysiologic Study versus Electrocardiographic Monitoring Investigators.
Mason JW
N Engl J Med; 1993 Aug; 329(7):452-8. PubMed ID: 8332150
[TBL] [Abstract][Full Text] [Related]
8. A perspective on the ESVEM trial current knowledge: sotalol should not be the first-line agent in the management of ventricular arrhythmias.
Garan H
Prog Cardiovasc Dis; 1996; 38(6):455-6. PubMed ID: 8638026
[TBL] [Abstract][Full Text] [Related]
9. The role of EP-guided therapy in ventricular arrhythmias: beta-blockers, sotalol, and ICD's.
Capucci A; Aschieri D; Villani GQ
J Interv Card Electrophysiol; 2000 Jan; 4 Suppl 1():57-63. PubMed ID: 10590490
[TBL] [Abstract][Full Text] [Related]
10. Arrhythmias in the intensive care patient.
Trappe HJ; Brandts B; Weismueller P
Curr Opin Crit Care; 2003 Oct; 9(5):345-55. PubMed ID: 14508146
[TBL] [Abstract][Full Text] [Related]
11. Sotalol for ventricular tachyarrhythmias: beta-blocking and class III contributions, and relative efficacy versus class I drugs after prior drug failure. ESVEM Investigators. Electrophysiologic Study Versus Electrocardiographic Monitoring.
Reiffel JA; Hahn E; Hartz V; Reiter MJ
Am J Cardiol; 1997 Apr; 79(8):1048-53. PubMed ID: 9114762
[TBL] [Abstract][Full Text] [Related]
12. Electrophysiologic basis for the antiarrhythmic actions of sotalol and comparison with other agents.
Singh BN
Am J Cardiol; 1993 Aug; 72(4):8A-18A. PubMed ID: 8346731
[TBL] [Abstract][Full Text] [Related]
13. Implications of the Electrophysiologic Study versus Electrocardiographic Monitoring trial for controlling ventricular tachycardia and fibrillation.
Reiffel JA
Am J Cardiol; 1996 Aug; 78(4A):34-40. PubMed ID: 8780327
[TBL] [Abstract][Full Text] [Related]
14. Antiarrhythmic actions of amiodarone: a profile of a paradoxical agent.
Singh BN
Am J Cardiol; 1996 Aug; 78(4A):41-53. PubMed ID: 8780328
[TBL] [Abstract][Full Text] [Related]
15. Pharmacodynamic, pharmacokinetic and antiarrhythmic properties of d-sotalol, the dextro-isomer of sotalol.
Advani SV; Singh BN
Drugs; 1995 May; 49(5):664-79. PubMed ID: 7601009
[TBL] [Abstract][Full Text] [Related]
16. [Antiarrhythmic therapy in patients with heart failure].
Faber TS; Zehender M
Ther Umsch; 2000 May; 57(5):324-32. PubMed ID: 10859993
[TBL] [Abstract][Full Text] [Related]
17. Practical considerations in the use of sotalol for ventricular tachycardia and ventricular fibrillation.
Campbell RW; Furniss SS
Am J Cardiol; 1993 Aug; 72(4):80A-85A. PubMed ID: 8346732
[TBL] [Abstract][Full Text] [Related]
18. [Therapy of atrial fibrillation with class III anti-arrhythmia agents].
Follath F; Candinas R; Frielingsdorf J
Herz; 1993 Feb; 18(1):20-6. PubMed ID: 8454249
[TBL] [Abstract][Full Text] [Related]
19. Enhanced efficacy of oral sotalol for sustained ventricular tachycardia refractory to type I antiarrhythmic drugs.
Kienzle MG; Martins JB; Wendt DJ; Constantin L; Hopson R; McCue ML
Am J Cardiol; 1988 May; 61(13):1012-7. PubMed ID: 3129926
[TBL] [Abstract][Full Text] [Related]
20. Drugs versus devices in controlling ventricular tachycardia, ventricular fibrillation, and recurrent cardiac arrest.
Haverkamp W; Eckardt L; Borggrefe M; Breithardt G
Am J Cardiol; 1997 Oct; 80(8A):67G-73G. PubMed ID: 9354413
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
